NCT02247063

Brief Summary

The investigators are doing a study to learn about the effects of a type of low-energy non-surgical electrical brain stimulation (HD-tDCS) on chronic pain in people's jaw joints. Disorders in these joints are called temporomandibular joint disorders, or TMD.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2013

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2013

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 18, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 23, 2014

Completed
3.2 years until next milestone

Results Posted

Study results publicly available

December 6, 2017

Completed
Last Updated

April 1, 2020

Status Verified

March 1, 2020

Enrollment Period

4 months

First QC Date

September 18, 2014

Results QC Date

November 8, 2017

Last Update Submit

March 23, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Pain Relief as Measured by Visual Analog Scale (VAS) Decrease of 50% or Greater From Baseline

    Self-reported VAS from 0 (no pain) to 10 (worst possible pain)

    Post tDCS sessions compared to baseline (one week)

Secondary Outcomes (1)

  • Number of Participants With Pain Relief as Measured by Visual Analog Scale (VAS) Decrease of 50% or Greater From Baseline

    One month after tDCS sessions compared to baseline (6 weeks)

Study Arms (2)

Placebo

SHAM COMPARATOR

The subjects in the placebo arm will participate in 5 daily M1 High-Definition Transcranial Direct Current Stimulation (HD-tDCS) sessions. During each session, a modular EEG recording cap will be placed on the subject's head and the anodal electrode will be placed on the motor cortex contralateral to the worst TMD pain side (C3). Current will be applied only for 30 seconds - this is a reliable method of sham stimulation (Gandiga et al., 2006) as sensations arising from tDCS treatment occur only at the beginning of application.

Device: High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

Experimental

EXPERIMENTAL

The subjects in the experimental arm will participate in 5 daily sessions. During each session, a modular EEG recording cap will be placed on the subject's head and the anodal electrode will be placed on the motor cortex contralateral to the worst TMD pain side (C3). Then 2mA of transcranial direct current stimulation will be applied for 20 minutes.

Device: High-Definition Transcranial Direct Current Stimulation (HD-tDCS)

Interventions

HD-tDCS is a non-invasive brain neuromodulatory method for M1 that involves sending a weak electrical current into your brain.

ExperimentalPlacebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Daily chronic TMD pain and dysfunction for at least one year (Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I Group I: Myofascial pain diagnosis\[15\]) not adequately controlled by previous conventional therapies (TMJ open-surgery naïve) for more than
  • year
  • Self-reported pain score of at least 3 on a 0-10 scale in spite of existing treatment in the two weeks preceding the onset of the study
  • Taking stable doses of medications for at least 4 weeks (if taking medications), and willing to limit the introduction of new medications for chronic TMD symptoms during the study

You may not qualify if:

  • Pain not primarily due to TMD
  • History or current evidence of a psychotic disorder (e.g. schizophrenia) or substance abuse by DSM-IV criteria; bipolar or severe major depression
  • History of neurological disorder (e.g. epilepsy, stroke, neuropathy, neuropathic pain)
  • Any severe clinical condition that in the opinion of the principal investigator interferes with the study
  • Pregnant or expecting to become pregnant during the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Temporomandibular Joint Disorders

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Results Point of Contact

Title
Thiago Nascimento
Organization
University of Michigan

Study Officials

  • Alexandre FM DaSilva, DDS, DMedSc

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 18, 2014

First Posted

September 23, 2014

Study Start

September 1, 2013

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

April 1, 2020

Results First Posted

December 6, 2017

Record last verified: 2020-03